This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated GAS1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-GAS1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~35.7 kDa | |
| Observed band | ~40 kDa | |
| Gel | 5–20% (catalog A06815-2) | |
| Positive control | Caudate (IHC candidate; verify WB) +4 more | |
| Negative control | Oral mucosa (IHC candidate; verify WB) |
| PTM | Glycosylated + Cleaved | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A06815-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human Hela, human HEK293 (catalog A06815-2) |
| Gel % | 5–20% (catalog A06815-2) |
| Load | 30 ug; reducing conditions (catalog A06815-2) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A06815-2) |
| Membrane | nitrocellulose membrane (catalog A06815-2) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog A06815-2) |
| Primary antibody | A06815-2 · 0.5 μg/mL (catalog A06815-2) |
| Primary incubation | overnight at 4°C (catalog A06815-2) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog A06815-2) |
| Secondary incubation | 1.5 hour at RT (catalog A06815-2) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog A06815-2) |
| Detection | ECL (catalog A06815-2) |
GAS1 is predicted at 35.7 kDa and observed near 40 kDa in reducing lysates; the cause of the difference is not established.
| Band near 40 kDa | Empirical GAS1 band in reducing whole-cell lysates; confirm identity with controls |
| Band near 35.7 kDa | Near the predicted precursor mass, not the validated band position |
| Band below the precursor position | May reflect signal-peptide or propeptide removal; identity needs confirmation |
| Band with altered mobility | N-linked glycosylation at Asn117 is possible; a visible shift is not established |
| Predicted precursor mass | 35.7 kDa is the sequence-based reference, while the observed band is near 40 kDa |
| N-linked glycosylation at Asn117 | Could alter migration, but the size or visibility of any shift is unknown |
| Signal peptide at residues 1–39 | Cleavage shortens the precursor; apparent mature size is not supplied |
| Propeptide at residues 319–345 | Removal shortens the precursor; apparent mature size is not supplied |
| Situation | Likely cause | Next action |
|---|---|---|
| Band higher than expected | Asn117 glycosylation could affect migration, but its contribution to the 40 kDa band is unestablished | Compare with deglycosylated sample and confirm band identity |
| Band lower than expected | Signal-peptide or propeptide cleavage could produce a shorter form | Check antibody epitope coverage and compare precursor and processed samples |
| Multiple bands | Processing or Asn117 glycosylation could produce different forms; distinct bands are unproven | Compare deglycosylated and untreated samples and verify each band's identity |
| Weak or no signal | GAS1 is GPI-anchored at the cell membrane, which can affect recovery in lysate | Check membrane-protein recovery and use a positive control |
| Fragments below expected size | Signal-peptide or propeptide removal is annotated, but smaller fragments are not characterized | Check epitope coverage and assess sample proteolysis with identity controls |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Caudate | glial cells | High | Protein (IHC) | HPA → |
| Cerebral cortex | neuronal cells | High | Protein (IHC) | HPA → |
| Endometrium | glandular cells | High | Protein (IHC) | HPA → |
| Epididymis | glandular cells | High | Protein (IHC) | HPA → |
| Gallbladder | glandular cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Oral mucosa | squamous epithelial cells | Not detected | Protein (IHC) | HPA → |
| Spleen | cells in red pulp | Not detected | Protein (IHC) | HPA → |
| Adipose tissue | adipocytes | Low | Protein (IHC) | HPA → |
| Duodenum | glandular cells | Low | Protein (IHC) | HPA → |
| Esophagus | squamous epithelial cells | Low | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for GAS1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Two anti-GAS1 antibodies have supplied Western blot images. A06815-2 shows an approximately 40 kDa band in human HeLa and HEK293 lysates. A06815-1 shows MCF-7 lysate with a peptide-blocked lane. The supplied evidence does not establish broad sample validation.
Which to pick: For human HeLa or HEK293 lysates, A06815-2 has a documented 40 kDa band and detailed blot conditions. A06815-1 lists human and mouse reactivity, but its supplied WB image uses MCF-7 cells; no mouse WB example is provided.